Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 1/20 | 0.42 |
| ▸ | GAA | P10253 | 2/20 | 0.33 |
| ▸ | MAPT | P10636 | 2/20 | 0.33 |
| ▸ | BCHE | P06276 | 2/20 | 0.32 |
| ▸ | ACHE | P22303 | 2/20 | 0.32 |
| ▸ | MEN1 | O00255 | 2/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.32 |
| ▸ | NOX1 | Q9Y5S8 | 2/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.32 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.32 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.32 |
| ▸ | MAOA | P21397 | 1/20 | 0.32 |
| ▸ | CNR1 | P21554 | 1/20 | 0.32 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.32 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.32 |
| ▸ | HTR2C | P28335 | 1/20 | 0.32 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25006 | 0.88 | ALOX5 (0.59) | ALOX5GAAMAPTMEN1KMT2A | |
| SCHEMBL2234492 | 0.82 | ALOX5 (0.38) | ALOX5 | |
| SCHEMBL1340168 | 0.72 | MMP12 (0.40) | GAAMAPTKMT2A | |
| SCHEMBL3292005 | 0.69 | — | — | |
| SCHEMBL4087192 | 0.69 | — | — | |
| SCHEMBL2551780 | 0.68 | MAOA (0.41) | CYP3A4MAOA | |
| SCHEMBL3585935 | 0.68 | GAA (0.37) | ALOX5GAAMAPTBCHEACHE | |
| SCHEMBL17418130 | 0.68 | GAA (0.41) | ALOX5GAAMAPTBCHEACHE | |
| SCHEMBL15741482 | 0.67 | DRD1 (0.38) | — | |
| SCHEMBL1449547 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 51 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3931176-B1 | HYDROGENATION OF IMINES WITH RU COMPLEXES | FIRMENICH & CIE (CH) | 2024-02-14 | — | — | EP | claimed |
| US-20220162181-A1 | HYDROGENATION OF IMINES WITH RU COMPLEXES | FIRMENICH SA (CH) | 2022-05-26 | — | — | US | claimed |
| CN-113950472-A | Hydrogenation of imines using RU complexes | 弗门尼舍有限公司 | 2022-01-18 | — | — | CN | claimed |
| EP-3931176-A1 | HYDROGENATION OF IMINES WITH RU COMPLEXES | Firmenich SA (CH) | 2022-01-05 | — | — | EP | claimed |
| US-20210371382-A1 | HYDROGENATION OF IMINES WITH RU COMPLEXES | FIRMENICH SA (CH) | 2021-12-02 | — | — | US | claimed |
| WO-2021023627-A1 | HYDROGENATION OF IMINES WITH RU COMPLEXES | FIRMENICH SA (CH) | 2021-02-11 | — | — | WO | claimed |
| EP-3700892-A1 | HYDROGENATION OF IMINES WITH RU COMPLEXES | Firmenich SA (CH) | 2020-09-02 | — | — | EP | claimed |
| CN-111417627-A | Hydrogenation of imines using RU complexes | 弗门尼舍有限公司 | 2020-07-14 | — | — | CN | claimed |
| EP-2747886-B1 | SELECTIVE HYDROGENATION OF ALDEHYDE WITH RU/BIDENTATE LIGANDS COMPLEXES | FIRMENICH & CIE (CH) | 2018-11-14 | — | — | EP | claimed |
| EP-2970067-B1 | SELECTIVE HYDROGENATION OF ALDEHYDES WITH RU/BIDENTATE LIGANDS COMPLEXES | FIRMENICH & CIE (CH) | 2017-08-16 | — | — | EP | claimed |
| US-20140243526-A1 | SELECTIVE HYDROGENATION OF ALDEHYDE WITH RU/BIDENTATE LIGANDS COMPLEXES | FIRMENICH SA (CH) | 2014-08-28 | — | — | US | claimed |
| EP-2747886-A1 | SELECTIVE HYDROGENATION OF ALDEHYDE WITH RU/BIDENTATE LIGANDS COMPLEXES | Firmenich SA (CH) | 2014-07-02 | — | — | EP | claimed |
| WO-2013050297-A1 | SELECTIVE HYDROGENATION OF ALDEHYDE WITH RU/BIDENTATE LIGANDS COMPLEXES | FIRMENICH SA (CH) | 2013-04-11 | — | — | WO | claimed |
| EP-2370207-A1 | HYDROGENATION OF ESTER, KETONE OR ALDEHYDE GROUPS WITH RUTHENIUM COMPLEXES HAVING A DI-AMINE AND A PHOSPHOROUS-NITROGEN BIDENTATE LIGAND | Firmenich S.A. (CH) | 2011-10-05 | — | — | EP | claimed |
| US-20110190523-A1 | HYDROGENATION OF ESTERS OR CARBONYL GROUPS WITH PHOSPHINO-OXIDE BASED RUTHENIUM COMPLEXES | FIRMENICH SA (CH) | 2011-08-04 | — | — | US | claimed |
| EP-2344276-A1 | HYDROGENATION OF ESTERS OR CARBONYL GROUPS WITH PHOSPHINO-OXIDE BASED RUTHENIUM COMPLEXES | Firmenich S.A. (CH) | 2011-07-20 | — | — | EP | claimed |
| WO-2010061350-A1 | HYDROGENATION OF ESTER, KETONE OR ALDEHYDE GROUPS WITH RUTHENIUM COMPLEXES HAVING A DI-AMINE AND A PHOSPHOROUS-NITROGEN BIDENTATE LIGAND | FIRMENICH SA (CH) | 2010-06-03 | — | — | WO | claimed |
| WO-2010038209-A1 | HYDROGENATION OF ESTERS OR CARBONYL GROUPS WITH PHOSPHINO-OXIDE BASED RUTHENIUM COMPLEXES | FIRMENICH SA (CH) | 2010-04-08 | — | — | WO | claimed |
| US-20090326188-A1 | Method for producing polyarylene | SUMITOMO CHEMICAL COMPANY, LIMITED | 2009-12-31 | — | — | US | claimed |
| EP-2065420-A1 | METHOD FOR PRODUCING POLYARYLENE | Sumitomo Chemical Company, Limited (JP) | 2009-06-03 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210371382-A1 | HYDROGENATION OF IMINES WITH RU COMPLEXES | HRH3, HRH4, HRH2 | ALOX5 3847/4885GAA 4446/4885MAPT 4241/4885 |
| US-20110190523-A1 | HYDROGENATION OF ESTERS OR CARBONYL GROUPS WITH PHOSPHINO-OXIDE BASED RUTHENIUM COMPLEXES | PNN, ADH5, NCL | ALOX5 158/4885GAA 3399/4885MAPT 4453/4885 |
| US-20140243526-A1 | SELECTIVE HYDROGENATION OF ALDEHYDE WITH RU/BIDENTATE LIGANDS COMPLEXES | ADH5, ADH1A, HAO2 | ALOX5 551/4885GAA 4536/4885MAPT 4325/4885 |
| US-20220162181-A1 | HYDROGENATION OF IMINES WITH RU COMPLEXES | HRH3, HNMT, HRH4 | ALOX5 3594/4885GAA 4486/4885MAPT 3016/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.